A Study to Evaluate the Efficacy and Safety of Efgartigimod PH20 Subcutaneous in Adult Patients With Primary Immune Thrombocytopenia
Clinical trial NCT04687072 · COMPLETED
Trial details
- NCT number
- NCT04687072
- Sponsor
- argenx
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-16
- Primary completion
- 2023-10-09
- Enrollment
- 207
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.